Skip to content
Recall Observatory FDA recall evidence

Drug product

Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25.

D-0576-2018

February 20, 2018

Class II

Product summary

Firm
Hospira Inc. A Pfizer Company
Event
Event 79238
Status
Terminated
Classification
Class II
Quantity
a) 137,975 vials; b) 40,143 vials
Official record key
drug-enforcement:D-0576-2018

Official wording

Reason: Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.

Code information: Lots: a) 74370DD, Exp 1FEB2019; 75035DD, 75115DD, Exp 1MAR2019; b) 74230DD, Exp 1FEB2019

Distribution pattern: Nationwide in the USA and Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.